Furthermore, the MetS group enhanced the expressions of Bax (1.2-fold of control), cytochrome c (1.8-fold of control), caspase-9 (6.0-fold of control) and caspase-3 (2.1-fold of control) compared with the control group. The gene discussed is BAX; the disease is metabolic syndrome.